The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Incidence of Childhood and Adolescent Melanoma in the United States: 1973–2009
Open accessAbstract
OBJECTIVE: Childhood and adolescent melanoma is rare but has been increasing. To gain insight into possible reasons underlying this observation, we analyzed trends in melanoma incidence diagnosed between the ages of 0 and 19 years among US whites by gender, stage, age at diagnosis, and primary site. We also investigated incidence trends by UV-B exposure levels. METHODS: By using Surveillance, Epidemiology, and End Results (SEER) program data (1973–2009), we calculated age-adjusted incidence rates (IRs), annual percent changes, and 95% confidence intervals for each category of interest. Incidence trends were also evaluated by using joinpoint and local regression models. SEER registries were categorized with respect to low or high UV-B radiation exposure. RESULTS: From 1973 through 2009, 1230 children of white race were diagnosed with malignant melanoma. Overall, pediatric melanoma increased by an average of 2% per year (95% confidence interval, 1.4%–2.7%). Girls, 15- to 19-year-olds, and individuals with low UV-B exposure had significantly higher IRs than boys, younger children, and those living in SEER registries categorized as high UV-B. Over the study period, boys experienced increased IRs for melanoma on the face and trunk, and females on the lower limbs and hip. The only decreased incidence trend we observed was among 15- to 19-year-olds in the high UV-B exposure group from 1985 through 2009. Local regression curves indicated similar patterns. CONCLUSIONS: These results may help elucidate possible risk factors for adolescent melanoma, but additional individual-level studies will be necessary to determine the reasons for increasing incidence trends.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective repair replication of DNA in xeroderma pigmentosum
CLEAVER, J. E. (1968) · Nature · doi:10.1038/218652a0 · Cited by 1,729
Indoor Tanning and Risk of Melanoma: A Case-Control Study in a Highly Exposed Population
Lazovich, D., Vogel, R. I., Berwick, M., Weinstock, M. A., Anderson, K. E., & Warshaw, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1249 · Cited by 353 · cited 1×
“3: Skin of other/unspecified parts of face 83 (7) 0.”
BackgroundBuller, D. B., Cokkinides, V., Hall, H. I., Hartman, A. M., Saraiya, M., Miller, E., Paddock, L., & Glanz, K. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.05.033 · Cited by 315
Linabery, A. M., & Ross, J. A. (2008) · Cancer · doi:10.1002/cncr.23866 · Cited by 246
Cited by
Cancer Incidence Rates and Trends Among Children and Adolescents in the United States, 2001–2009
Siegel, D. A., King, J., Tai, E., Buchanan, N., Ajani, U. A., & Li, J. (2014) · Pediatrics · doi:10.1542/peds.2013-3926 · Cited by 275
Ultraviolet Radiation Exposure and Its Impact on Skin Cancer Risk
Watson, M., Holman, D. M., & Maguire-Eisen, M. (2016) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2016.05.005 · Cited by 275
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
Geoerger, B., Bergeron, C., Gore, L., Sender, L., Dunkel, I. J., Herzog, C., Brochez, L., Cruz, O., Nysom, K., Berghorn, E., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.032 · Cited by 98
Prevalence of major risk factors and use of screening tests for cancer in the United States
Fedewa, S. A., Sauer, A. G., Siegel, R. L., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0134 · Cited by 77
Metadata
- Authors
- Wong, J. R., Harris, J. K., Rodriguez-Galindo, C., & Johnson, K. J.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2013-05-01
- Volume
- 131
- Issue
- 5
- Pages
- 846-854
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2155200541
- Cited by
- 173
- References
- 4
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.